Properties
What is it?
Composition: 1 ml of oral solution contains L-Carnitine 100 mg. Excipients: Oral solution 1g-10ml: Malic acid, Sodium benzoate, Sodium saccharin dehydrate, Orange flavor, Purified water; Injection solution 1g-5ml ampoule: 1 ml of injection solution contains L-Carnitine 200 mg. Excipients: Water for injection, Hydrochloric acid. Indications: Primary (genetic) and secondary carnitine deficiency, patients with chronic renal failure undergoing hemodialysis; cardiomyopathy, ischemic heart disease, heart failure, fatty dystrophy of the heart, arrhythmia; stroke, neuritis, encephalopathy, myopathy, multiple sclerosis, Alzheimer's disease; body mass deficit and growth retardation in children and adolescents; neonatal asphyxia, birth trauma: neonatal hypotrophy and hypotonia, premature infants; intensive physical and mental exertion; hypoacid and antacid gastritis, pancreatitis, cholecystitis, liver failure and fatty dystrophy; diabetes mellitus, mild form of thyrotoxicosis, obesity; male infertility (oligospermia, azoospermia), decreased work capacity and chronic fatigue; pregnancy toxemia. Dosage and Administration: Oral administration: Administer 30 minutes before meals, must be diluted in liquid (water or fruit juice). For chronic conditions of primary and secondary L-Carnitine deficiency - 100-200 mg/kg daily, divided into 2-4 doses, in acute conditions - 400 mg/kg daily. In children under 2 years: 150 mg/kg body weight; 2-6 years: 100 mg/kg body weight; 6-12 years: 75 mg/kg body weight; over 12 years and adults: daily dose 2-3g. During hemodialysis 2-4g; angina and post-infarction condition: 2-6g per day. Intravenous use: Administer IV or IM; during IV injection, the drug is administered slowly over 2-3 minutes. In case of severe metabolic disorders, administer intravenously 50-100 mg/kg daily, divided into 3-4 doses. If necessary, very high doses can be used in adults with secondary L-Carnitine deficiency in patients with end-stage renal failure requiring blood purification (hemodialysis). One dose of 10-20 mg/kg is administered intravenously at the end of the hemodialysis session, for three weeks. In children: 50-100 mg/kg body weight. In adults: 1-3g per day. Treatment starts with 1g per day, the dose of the drug can be increased up to 3g per day. During hemodialysis 2g once (after the procedure). Acute myocardial infarction: 100-200 mg/kg body weight divided into two doses per day or continuous administration of the drug for the first 48 hours, followed by halving the subsequent dose. Contraindications: Hypersensitivity to the components of the preparation. Storage: Store in a dry, protected from light place at a temperature of 25C. Do not use after the expiry date indicated on the packaging.